These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25904441)

  • 21. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
    Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
    Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.
    Li J; Li H; Wu H; Niu H; Li H; Pan J; Yang J; Tan T; Hu C; Xu T; Zhang X; Zheng M; Li K; Zou Y; Yang T
    BMC Pediatr; 2020 May; 20(1):200. PubMed ID: 32386507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for hepatoblastoma.
    Faraj W; Dar F; Marangoni G; Bartlett A; Melendez HV; Hadzic D; Dhawan A; Mieli-Vergani G; Rela M; Heaton N
    Liver Transpl; 2008 Nov; 14(11):1614-9. PubMed ID: 18975296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
    Héry G; Franchi-Abella S; Habes D; Brugières L; Martelli H; Fabre M; Pariente D; Gauthier F; Jacquemin E; Branchereau S
    Pediatr Blood Cancer; 2011 Dec; 57(7):1270-5. PubMed ID: 21910210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
    Kusano T; Aoki H; Kinjo T; Miyazato H; Shimoji H; Isa T; Muto Y
    J Hepatobiliary Pancreat Surg; 2000; 7(4):410-6. PubMed ID: 11180863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
    Brown J; Perilongo G; Shafford E; Keeling J; Pritchard J; Brock P; Dicks-Mireaux C; Phillips A; Vos A; Plaschkes J
    Eur J Cancer; 2000 Jul; 36(11):1418-25. PubMed ID: 10899656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
    Kubota M; Yagi M; Kanada S; Yamazaki S; Tanaka S; Asami K; Ogawa A; Watanabe A; Iwabuchi H; Kaneko M; Saida Y
    J Pediatr Surg; 2004 Dec; 39(12):1775-8. PubMed ID: 15616926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation.
    Tiao GM; Bobey N; Allen S; Nieves N; Alonso M; Bucuvalas J; Wells R; Ryckman F
    J Pediatr; 2005 Feb; 146(2):204-11. PubMed ID: 15689909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma.
    Bajpai M; Pal K; Agarwala S; Seth T; Gupta AK
    Pediatr Surg Int; 2005 May; 21(5):364-8. PubMed ID: 15838617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal hepatoblastoma: What is the risk of recurrent disease in the remnant liver?
    Fahy AS; Shaikh F; Gerstle JT
    J Pediatr Surg; 2019 May; 54(5):1035-1040. PubMed ID: 30819543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
    Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between surgical margins and long-term outcome in advanced hepatoblastoma.
    Dicken BJ; Bigam DL; Lees GM
    J Pediatr Surg; 2004 May; 39(5):721-5. PubMed ID: 15137006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
    J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D;
    Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical strategies for unresectable hepatoblastomas.
    Tajiri T; Kimura O; Fumino S; Furukawa T; Iehara T; Souzaki R; Kinoshita Y; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Hishiki T; Hosoi H; Hiyama E; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2194-8. PubMed ID: 23217875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.